Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36(+ 0) weeks gestation

BACKGROUND: Forty percent of babies who are stillborn born die after 36 weeks gestation and have no lethal structural abnormality. Maternal perception of reduced fetal movement (RFM) is associated with stillbirth and is related to abnormal placental structure and function. The ultimate objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong-Buisseret, Lindsay, Mitchell, Eleanor, Hepburn, Trish, Duley, Lelia, Thornton, Jim G., Roberts, Tracy E., Storey, Claire, Smyth, Rebecca, Heazell, Alexander E. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167841/
https://www.ncbi.nlm.nih.gov/pubmed/30285835
http://dx.doi.org/10.1186/s13063-018-2859-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167841/
https://www.ncbi.nlm.nih.gov/pubmed/30285835
http://dx.doi.org/10.1186/s13063-018-2859-1

Ejemplares similares